Nocturnal’s is committed to supporting the development of medical breakthrough technologies by providing its clients multiple levels of funding.
We take the long-term success of our clients very seriously, which means providing them with as much support as possible on their path to market.
In order to assist our clients in obtaining the funding they need to develop and commercialize their technologies, Nocturnal has partnered with Techwald, S.p.A. - a medical device holdings company based in Milan.
Techwald invests in early-stage medical device companies and provides guidance for commercialization strategy in the European medical device marketplace. By providing a direct connection to funding, Nocturnal is able not only to assist clients in the product development process but also in procuring the financial resources necessary to pursue it.